You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • Harnessing radiotherapy-induced NK-cell activity by combining DNA damage–response inhibition and immune checkpoint blockade

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Harnessing radiotherapy-induced NK-cell activity by combining DNA damage–response inhibition and immune checkpoint blockade

 

Online download statistics by month:

Online download statistics by month: March 2022 to July 2025

AbstractFullPdf
Mar 2022703739212
Apr 2022364379152
May 2022404412145
Jun 2022438468146
Jul 2022245264107
Aug 202223523577
Sep 2022204207137
Oct 202222222989
Nov 202219119195
Dec 202215315453
Jan 202315615655
Feb 202313613765
Mar 202312112257
Apr 202310610853
May 202311411549
Jun 2023929334
Jul 202310010360
Aug 202310010057
Sep 202310710844
Oct 202311311453
Nov 2023828250
Dec 2023919246
Jan 2024848448
Feb 2024919448
Mar 2024105105189
Apr 2024868653
May 2024828227
Jun 202412012259
Jul 2024848439
Aug 2024737249
Sep 2024949447
Oct 202411811866
Nov 202410812059
Dec 202412413165
Jan 2025929348
Feb 202510110269
Mar 2025959654
Apr 202512812957
May 202510310668
Jun 2025727231
Jul 2025110
Total623863992912